Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy

Background and Aims: With the availability of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection and changing liver disease etiology for liver transplantation (LT), data on the changes in LT recipient population in the DAA era are scanty. Methods: The United Network for Orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Chencheng, Kuo, Yong-Fang, Singal, Ashwani K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562800/
https://www.ncbi.nlm.nih.gov/pubmed/33083248
http://dx.doi.org/10.14218/JCTH.2020.00032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562800/
https://www.ncbi.nlm.nih.gov/pubmed/33083248
http://dx.doi.org/10.14218/JCTH.2020.00032

Ejemplares similares